methylprednisolone has been researched along with Jaundice, Cholestatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braddock, M; Cai, WW; Jin, L; Wang, LR; Zheng, MH; Zou, H | 1 |
| Albarrán Severo, B; Álvarez Artero, E; Campo Núñez, A; Pardo-Lledias, J | 1 |
2 other study(ies) available for methylprednisolone and Jaundice, Cholestatic
| Article | Year |
|---|---|
Methimazole-induced cholestatic hepatitis: two cases report and literature review.
Topics: Adult; Anti-Inflammatory Agents; Antithyroid Agents; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis; Humans; Hyperthyroidism; Jaundice, Obstructive; Methimazole; Methylprednisolone; Middle Aged; Prognosis | 2016 |
Severe liver disease as first sign of a haemophagocytic syndrome.
Topics: Acute Kidney Injury; Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Bone Marrow; Cerebral Hemorrhage; Dexamethasone; Etoposide; Fatal Outcome; Humans; Jaundice, Obstructive; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Middle Aged; Pseudomonas Infections; Sepsis; Splenomegaly | 2017 |